All lobbying filings

LMH STRATEGIC SOLUTIONS

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Biopharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $30,000.00 income · posted Apr 18, 2025

Official filing document

Bills named in this filing 2

HR 1509
Accelerating Kids’ Access to Care Act of 2025
S 752
Accelerating Kids’ Access to Care Act

Lobbying activity 1

Health Issues

Access for inpatient gene therapies Monitor newborn screening issues. Pediatric Review Reauthorization. H.R.1509/S.752 - Accelerating Kids Access to Care Act of 2025.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.